Challenger Ltd
F:GK9
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Challenger Ltd
F:GK9
|
AU |
|
H
|
HEM Pharma Inc
KOSDAQ:376270
|
KR |
|
Q
|
QuadMedicine Inc
KOSDAQ:464490
|
KR |
|
T
|
Teleservice AG
XMUN:TH51
|
DE |
|
S
|
Skardin Industrial Corp
TPEX:3466
|
TW |
|
A
|
Azion Corp
TPEX:6148
|
TW |
|
Schouw & Co A/S
F:5RF
|
DK |
|
H
|
Hydaway Ventures Corp
XTSX:HIDE.P
|
CA |
|
H
|
Hana 31 Special Purpose Acquisition Co
KOSDAQ:469900
|
KR |
Wall St Price Targets
GK9 Price Targets Summary
Challenger Ltd
According to Wall Street analysts, the average 1-year price target for GK9 is 5.35 EUR with a low forecast of 4.37 EUR and a high forecast of 6.15 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is GK9's stock price target?
Price Target
5.35
EUR
According to Wall Street analysts, the average 1-year price target for GK9 is 5.35 EUR with a low forecast of 4.37 EUR and a high forecast of 6.15 EUR.
What is the Revenue forecast for Challenger Ltd?
Projected CAGR
-5%
Over the last 13 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 8 years is -5%.
What is the Operating Income forecast for Challenger Ltd?
Projected CAGR
1%
Over the last 13 years, the compound annual growth rate for Operating Income has been 17%. The projected CAGR for the next 8 years is 1%.
What is the Pre-Tax Income forecast for Challenger Ltd?
Projected CAGR
41%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 5%. The projected CAGR for the next 3 years is 41%.
What is the Net Income forecast for Challenger Ltd?
Projected CAGR
21%
Over the last 13 years, the compound annual growth rate for Net Income has been 2%. The projected CAGR for the next 8 years is 21%.
